Eloxx Pharmaceuticals, Inc. Common Stock ELOX
$18.76
-1.63%
at last close
Market Cap$64.47 million
P/E Ratio—
Div Yield—
Volume29.6K
52-Week Range
$0.00$19.96
Analyst Ratings
- Consensus
- Buy — 2 Buy · 0 Hold · 0 Sell (2 analysts)
- Avg. Price Target
- $41.50 (+121.2% upside)
Key Stats
- Today's Range
- $17.17 – $19.23
- 50-Day Range
- $3.96 – $19.96
- 52-Week Range
- $0.00 – $19.96
- Volume
- 30K shs
- Average Volume
- 60K shs
- Market Cap
- $64.47 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 1.39
- Price / Sales
- —
Short Interest
- Short Interest
- 0.01%
- Days to Cover
- 1.00
About Eloxx Pharmaceuticals, Inc. Common Stock
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.
Related Stocks
Compare head-to-head: ELOX vs AMGN·ELOX vs HALO·ELOX vs KYMR·ELOX vs RGEN
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.